Liliana Santos

Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Positive Breast Cancer

Lipopolysaccharide Induced

Cerebral Ischemia

Top Venues

The Journal of pathology

International journal of molecular sciences

Journal of cellular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Carvalho, Liliana Santos, Inês Conde, Ricardo Leitão, Hugo R S Ferreira, Célia M F Gomes, Ana Paula Silva, Fernando Schmitt, Carina Carvalho-Maia, João Lobo, Carmen Jerónimo, Joana Paredes, Ana Sofia Ribeiro
Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain. The Journal of pathology 264 (2) (2024)
Rita Carvalho, Liliana Santos, Inês Conde, Ricardo Leitão, Hugo R S Ferreira, Célia M F Gomes, Ana Paula Silva, Fernando Schmitt, Carina Carvalho-Maia, João Lobo, Carmen Jerónimo, Joana Paredes, Ana Sofia Ribeiro
Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain. The Journal of pathology (2024)
Liliana Santos, Francesca Tomatis, Hugo R S Ferreira, Sara F F Almeida, Edward Ciputra, José Sereno, Rui Almeida, Paulo Teixeira, Ana Sofia Ribeiro, João Nuno Moreira, Ana Paula Silva, Lino S Ferreira, Antero José Abrunhosa, Célia M Gomes
ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer. Neuro-oncology (2024)
Ivanna Hrynchak, Liliana Santos, Amílcar Falcão, Célia M F Gomes, Antero José Abrunhosa
Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies. International journal of molecular sciences 22 (19) (2021)
Marina Couto, Vanessa Coelho-Santos, Liliana Santos, Carlos Fontes Ribeiro, Ana Paula Silva, Célia M F Gomes
The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway. Journal of cellular physiology 234 (11) (2019)